Livedoid vasculitis - Vasculite Livedoidhttps://en.wikipedia.org/wiki/Livedoid_vasculitis
☆ In i risultati Stiftung Warentest 2022 da Germania, a satisfaczione di i cunsumatori cù ModelDerm era solu ligeramente più bassu chè cù cunsultazioni di telemedicina pagate. Pò esse accumpagnatu da u dulore.
relevance score : -100.0%
References Livedoid vasculopathy: A review with focus on terminology and pathogenesis 36285834 NIH
Livedoid vasculopathy hè una cundizione rara di a pelle carattarizata da ulcere dolorose chì cuntinueghjanu à vultà nantu à e gambe inferiori.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy: A review of pathogenesis and principles of management 27297279Livedoid vasculopathy hè una cundizione rara di a pelle chì provoca ulcere recurrenti in i gambe inferiori, lascendu cicatrici pallide cunnisciute cum'è atrophie blanche. Mentre a causa esatta ùn hè ancu chjaru, si crede chì l'aumentu di a coagulazione di u sangue (hypercoagulability) hè u fattore principale, cù a inflamazioni chì ghjucanu un rolu secundariu. I fatturi chì cuntribuiscenu à a coagulazione includenu i seguenti - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In i biopsie, a cundizione mostra coaguli di sangue in i vasi, ingrossi di i muri di i vasi, è cicatrici. U trattamentu implica un approcciu multi-pronged chì si focalizeghja nantu à a prevenzione di i coaguli di sangue cù medicazione cum'è droghe anti-platelet, diluenti di sangue è terapia fibrinolitica. Diversi droghe ponu esse aduprate per sta cundizione di a pelle - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid Vasculopathy 32644463 NIH
Livedoid vasculopathy hè una cundizione rara induve e lesioni si prisentanu à e duie gambe. A furmazione di coaguli di sangue in i vini sanguini hè pensata per esse causata da un aumentu di a coagulazione è a riduzzione di a rottura di i coaguli, inseme cù danni à u rivestimentu di u vasu. Hè più cumuni in e femine, in particulare trà l'età di 15 è 50. Smetti di fumà, cura di e ferite, è l'usu di medicazione cum'è diluenti di sangue è droghe antiplatelet sò stati efficace.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.